G-III Apparel Group, Ltd. Announces Fourth Quarter and Full-Year Fiscal 2013 Results
— Net Sales Increase by 28% to
—Net Income Per Diluted Share Increases to
— Non-GAAP Net Income Per Share is
For the fiscal year ended
Reconciliations of GAAP net income per share to Non-GAAP net income per share and of GAAP net income to adjusted EBITDA are presented in tables accompanying the condensed financial statements included in this release. The Non-GAAP net income per share and adjusted EBITDA for the full fiscal year reflect an adjustment to exclude the expenses and integration costs associated with the Vilebrequin acquisition. Non-GAAP net income per share and adjusted EBITDA should be evaluated in light of the Company's financial results prepared in accordance with GAAP.
For the three-month period ended
Outlook
Also today,
The Company is forecasting net sales of approximately
About
G-III is a leading manufacturer and distributor of outerwear, dresses,
sportswear, swimwear, beachwear and women's suits, as well as handbags
and luggage, under licensed brands, our own brands and private label
brands. G-III sells swimwear, resort wear and related accessories under
our own Vilebrequin brand. G-III also sells outerwear, dresses,
performance wear and handbags under our own
Statements concerning G-III's business outlook or future economic
performance, anticipated revenues, expenses or other financial items;
product introductions and plans and objectives related thereto; and
statements concerning assumptions made or expectations as to any future
events, conditions, performance or other matters are "forward-looking
statements" as that term is defined under the
|
||||||||||||||
(NASDAQ:GIII) | ||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||
(In thousands, except per share amounts) |
||||||||||||||
(Unaudited) |
||||||||||||||
|
Three Months Ended |
Twelve Months Ended |
||||||||||||
|
|
|
|
|
||||||||||
Net sales | $ | 375,277 | $ | 294,346 | $ | 1,399,719 | $ | 1,231,201 | ||||||
Cost of sales | 257,380 | 210,931 | 948,082 | 860,485 | ||||||||||
Gross profit | 117,897 | 83,415 | 451,637 | 370,716 | ||||||||||
Selling, general and administrative expenses |
98,887 |
72,310 |
341,242 |
277,019 |
||||||||||
Depreciation and amortization | 2,943 | 2,222 | 9,907 | 7,473 | ||||||||||
Operating profit | 16,067 | 8,883 | 100,488 | 86,224 | ||||||||||
Equity loss in joint venture | 13 | 460 | 719 | 1,271 | ||||||||||
Interest and financing charges, net | 2,553 | 1,705 | 7,764 | 5,713 | ||||||||||
Income before taxes | 13,501 | 6,718 | 92,005 | 79,240 | ||||||||||
Income tax expense | 5,604 | 1,699 | 35,436 | 29,620 | ||||||||||
Net income | 7,897 | 5,019 | 56,569 | 49,620 | ||||||||||
Add: Loss attributable to noncontrolling interest | 173 | - | 306 | - | ||||||||||
Income attributable to G-III | $ | 8,070 | $ | 5,019 | $ | 56,875 | $ | 49,620 | ||||||
Net income per common share: | ||||||||||||||
Basic | $ | 0.40 | $ | 0.25 | $ | 2.84 | $ | 2.51 | ||||||
Diluted | $ | 0.40 | $ | 0.25 | $ | 2.80 | $ | 2.46 | ||||||
Weighted average shares outstanding: | ||||||||||||||
Basic | 20,111 | 19,769 | 20,006 | 19,796 | ||||||||||
Diluted | 20,375 | 20,106 | 20,280 | 20,192 | ||||||||||
Selected Balance Sheet Data (in thousands): |
At January 31, |
|||||||||
2013 |
2012 |
|||||||||
Cash | $ | 27,360 | $ | 24,660 | ||||||
Working Capital | 283,369 | 288,259 | ||||||||
Inventory | 280,929 | 253,521 | ||||||||
Total Assets | 717,772 | 546,103 | ||||||||
Short-term Revolving Debt | 65,000 | 30,050 | ||||||||
Long-term Notes Payable | 19,778 | - | ||||||||
Total Stockholders' Equity | 429,240 | 357,972 | ||||||||
|
|||||||||||||||
RECONCILIATION OF ACTUAL GAAP NET INCOME PER SHARE TO ACTUAL |
|||||||||||||||
NON-GAAP NET INCOME PER SHARE |
|||||||||||||||
(Unaudited) |
|||||||||||||||
Three Months Ended
|
Year Ended January 31, |
||||||||||||||
2013 |
2012 |
2013 |
2012 |
||||||||||||
GAAP diluted net income per common share |
$ |
0.40 |
$ |
0.25 |
$ |
2.80 |
$ |
2.46 |
|||||||
Excluded from Non-GAAP: |
|||||||||||||||
Expenses associated with Vilebrequin acquisition, net of taxes | 0.01 | - | 0.12 | - | |||||||||||
Non-GAAP diluted net income per common share | $ | 0.41 | $ | 0.25 | $ | 2.92 | $ | 2.46 | |||||||
Non-GAAP diluted net income per share is a "non-GAAP financial measure"
that excludes the expenses and integration costs associated with the
acquisition of Vilebrequin. The non-GAAP information in the tables above
reflects an adjustment for expenses and integration costs associated
with the Vilebrequin acquisition that were incurred through
|
|||||||||
RECONCILIATION OF ACTUAL NET INCOME TO ACTUAL ADJUSTED EBITDA | |||||||||
(In thousands) |
|||||||||
(Unaudited) |
|||||||||
|
Actual Twelve Months Ended
|
Actual Twelve Months Ended
|
|||||||
Net income | $ | 56,875 | $ | 49,620 | |||||
Expenses associated with Vilebrequin acquisition | 3,970 | - | |||||||
Depreciation and amortization | 9,907 | 7,473 | |||||||
Interest and financing charges, net | 7,764 | 5,713 | |||||||
Income tax expense | 35,436 | 29,620 | |||||||
Adjusted EBITDA, as defined | $ | 113,952 | $ | 92,426 | |||||
Adjusted EBITDA is a "non-GAAP financial measure" which represents
earnings before depreciation and amortization, interest and financing
charges, net, and income tax expense and excludes expenses and
integration costs related to the acquisition of Vilebrequin. The
non-GAAP information in the table above reflects an adjustment for
expenses and integration costs associated with the Vilebrequin
acquisition that were incurred through
For
Investor Relations
or
Chief Financial Officer
Source:
News Provided by Acquire Media